Cargando…

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellsagué, Xavier, Paavonen, Jorma, Jaisamrarn, Unnop, Wheeler, Cosette M, Skinner, S Rachel, Lehtinen, Matti, Naud, Paulo, Chow, Song-Nan, Del Rosario-Raymundo, Maria Rowena, Teixeira, Julio C, Palmroth, Johanna, de Carvalho, Newton S, Germar, Maria Julieta V, Peters, Klaus, Garland, Suzanne M, Szarewski, Anne, Poppe, Willy AJ, Romanowski, Barbara, Schwarz, Tino F, Tjalma, Wiebren AA, Bosch, F Xavier, Bozonnat, Marie-Cecile, Struyf, Frank, Dubin, Gary, Rosillon, Dominique, Baril, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251672/
https://www.ncbi.nlm.nih.gov/pubmed/25927224
http://dx.doi.org/10.1186/s12879-014-0551-y
_version_ 1782347079611318272
author Castellsagué, Xavier
Paavonen, Jorma
Jaisamrarn, Unnop
Wheeler, Cosette M
Skinner, S Rachel
Lehtinen, Matti
Naud, Paulo
Chow, Song-Nan
Del Rosario-Raymundo, Maria Rowena
Teixeira, Julio C
Palmroth, Johanna
de Carvalho, Newton S
Germar, Maria Julieta V
Peters, Klaus
Garland, Suzanne M
Szarewski, Anne
Poppe, Willy AJ
Romanowski, Barbara
Schwarz, Tino F
Tjalma, Wiebren AA
Bosch, F Xavier
Bozonnat, Marie-Cecile
Struyf, Frank
Dubin, Gary
Rosillon, Dominique
Baril, Laurence
author_facet Castellsagué, Xavier
Paavonen, Jorma
Jaisamrarn, Unnop
Wheeler, Cosette M
Skinner, S Rachel
Lehtinen, Matti
Naud, Paulo
Chow, Song-Nan
Del Rosario-Raymundo, Maria Rowena
Teixeira, Julio C
Palmroth, Johanna
de Carvalho, Newton S
Germar, Maria Julieta V
Peters, Klaus
Garland, Suzanne M
Szarewski, Anne
Poppe, Willy AJ
Romanowski, Barbara
Schwarz, Tino F
Tjalma, Wiebren AA
Bosch, F Xavier
Bozonnat, Marie-Cecile
Struyf, Frank
Dubin, Gary
Rosillon, Dominique
Baril, Laurence
author_sort Castellsagué, Xavier
collection PubMed
description BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models. RESULTS: A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development. CONCLUSIONS: More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation. TRIAL REGISTRATION: clinicaltrials.gov: NCT00122681. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0551-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4251672
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42516722014-12-03 Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial Castellsagué, Xavier Paavonen, Jorma Jaisamrarn, Unnop Wheeler, Cosette M Skinner, S Rachel Lehtinen, Matti Naud, Paulo Chow, Song-Nan Del Rosario-Raymundo, Maria Rowena Teixeira, Julio C Palmroth, Johanna de Carvalho, Newton S Germar, Maria Julieta V Peters, Klaus Garland, Suzanne M Szarewski, Anne Poppe, Willy AJ Romanowski, Barbara Schwarz, Tino F Tjalma, Wiebren AA Bosch, F Xavier Bozonnat, Marie-Cecile Struyf, Frank Dubin, Gary Rosillon, Dominique Baril, Laurence BMC Infect Dis Research Article BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models. RESULTS: A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development. CONCLUSIONS: More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation. TRIAL REGISTRATION: clinicaltrials.gov: NCT00122681. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0551-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-30 /pmc/articles/PMC4251672/ /pubmed/25927224 http://dx.doi.org/10.1186/s12879-014-0551-y Text en © Castellsagué et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Castellsagué, Xavier
Paavonen, Jorma
Jaisamrarn, Unnop
Wheeler, Cosette M
Skinner, S Rachel
Lehtinen, Matti
Naud, Paulo
Chow, Song-Nan
Del Rosario-Raymundo, Maria Rowena
Teixeira, Julio C
Palmroth, Johanna
de Carvalho, Newton S
Germar, Maria Julieta V
Peters, Klaus
Garland, Suzanne M
Szarewski, Anne
Poppe, Willy AJ
Romanowski, Barbara
Schwarz, Tino F
Tjalma, Wiebren AA
Bosch, F Xavier
Bozonnat, Marie-Cecile
Struyf, Frank
Dubin, Gary
Rosillon, Dominique
Baril, Laurence
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title_full Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title_fullStr Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title_full_unstemmed Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title_short Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
title_sort risk of first cervical hpv infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled patricia trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251672/
https://www.ncbi.nlm.nih.gov/pubmed/25927224
http://dx.doi.org/10.1186/s12879-014-0551-y
work_keys_str_mv AT castellsaguexavier riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT paavonenjorma riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT jaisamrarnunnop riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT wheelercosettem riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT skinnersrachel riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT lehtinenmatti riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT naudpaulo riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT chowsongnan riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT delrosarioraymundomariarowena riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT teixeirajulioc riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT palmrothjohanna riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT decarvalhonewtons riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT germarmariajulietav riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT petersklaus riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT garlandsuzannem riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT szarewskianne riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT poppewillyaj riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT romanowskibarbara riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT schwarztinof riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT tjalmawiebrenaa riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT boschfxavier riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT bozonnatmariececile riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT struyffrank riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT dubingary riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT rosillondominique riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT barillaurence riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial
AT riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial